Characteristics of 91 male patients with Parkinson’s disease who returned the questionnaire
| Characteristic | All (n = 91) | Free T <70 pg/ml (n = 19) | Free T >70 pg/ml (n = 23) | |
|---|---|---|---|---|
| BDI, Beck depression inventory; HRT, hormone replacement therapy; T, testosterone. | ||||
| Age (years) | ||||
| Mean | 64 | 71 | 61 | |
| SD | 10 | 9 | 10 | |
| Range | 40 to 89 | 55 to 89 | 44 to 83 | |
| HRT (% of patients) | 10% | 21% | 4% | |
| Free testosterone level (pg/ml) | ||||
| <70 | 19 (45%) | 19 (100%) | 0 (0%) | |
| >70 | 23 (55%) | 0 (0%) | 23 (100%) | |
| Mean | 82.1 | 49.0 | 109.4 | |
| SD | 41.6 | 13.6 | 36.7 | |
| Range | 4.1 to 196.1 | 4.1 to 65.7 | 71.2 to 196.1 | |
| St Louis score | ||||
| ⩾3 | 85 (93%) | 18 (95%) | 22 (96%) | |
| <3 | 6 (7%) | 1 (5%) | 1 (4%) | |
| Mean | 5.9 | 6.6 | 5.8 | |
| SD | 2.3 | 2.2 | 2.2 | |
| Range | 0 to 10 | 2 to 10 | 2 to 10 | |
| BDI score | ||||
| Mean | 9.2 | 10.5 | 9.3 | |
| SD | 6.0 | 6.7 | 5.4 | |
| Range | 0 to 31 | 2 to 22 | 0 to 19 | |
| Number of antidepressants | ||||
| Current: | 0 | 51 (56%) | 7 (37%) | 13 (57%) |
| 1 | 37 (41%) | 11 (58%) | 10 (43%) | |
| >1 | 3 (3%) | 1 (5%) | 0 (0%) | |
| Lifetime: | 0 | 35 (38%) | 4 (21%) | 9 (39%) |
| 1 | 27 (30%) | 10 (53%) | 4 (17%) | |
| 2 | 15 (16%) | 1 (5%) | 6 (26%) | |
| 3 | 10 (11%) | 3 (16%) | 2 (9%) | |
| >3 | 4 (4%) | 1 (5%) | 2 (9%) | |